BH
Bausch Health
BHC · NYSE
$6.17 -4.04% (-$0.26)
1M -1.28%
Market Cap $2.31B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$6.89
11.7% upside
Trenutna cena
$6.17
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BHC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
89 /100
Cheap P/S 0.21x
P/FCF 1.66x
EV/EBITDA 10.39x
Growth
61 /100
Stable Rev. growth 8.74%
FCF growth N/A
Book val. growth N/A
Profitability
73 /100
Strong Net margin 10.12%
Op. margin 25.44%
FCF margin 12.83%
Quality
64 /100
Average ROA 4.43%
Asset turnover 0.44x
ROIC 19.51%
Debt
17 /100
High Int. coverage 0.54x
Net debt/EBITDA 9.26x
Current ratio 1.44x
Stability
44 /100
Moderate Rev. volatility 1.08%
EPS volatility 297.06%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BHC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Thomas J. Appio
Employees
20,300
Headquarters
Laval
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report